Simplifying Global Compliance
FDA Blocks Additional Versions of Generic Norvasc
Washington Drug Letter
FDA has barred all approvals for generic versions of Pfizer's Norvasc except for one issued earlier to Mylan, the agency announced in a notice to the U.S. District Court for the District of Columbia.
To View This Article:
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing